Squarex
7460 Pinehurst Road
Pine Springs
Minnesota
55115
United States
Tel: 651-492-0283
Website: http://squarex-pharma.com
About Squarex
Squarex LLC is a privately held pharmaceutical development company.LEADERSHIP:
Founder: Hugh McTavish
CLINICAL TRIAL:
Please click here for clinical trial information.
6 articles about Squarex
-
Squarex Announces Positive Results from Completed Phase 2 Study of SQX770 in the Prevention of Recurrent Herpes Labialis
8/5/2019
Squarex, a clinical-stage pharmaceutical company developing a topical immunomodulator for the long-term prevention of recurrent cold sores and other infections caused by herpes simplex viruses, today announced positive results from a Phase 2 study of its investigational compound SQX770
-
BioSpace Movers and Shakers: July 3
7/3/2019
Biotech and pharma companies strengthen their executive leadership and board positions. -
Squarex Appoints Biopharmaceutical Industry Veteran Jack V. Talley as Chief Executive Officer
7/1/2019
Squarex, a clinical-stage pharmaceutical company developing a topical immunomodulator for the long-term prevention of recurrent cold sores and other diseases, today announced the appointment of Jack V. Talley, Jr. as Chief Executive Officer.
-
Squarex to Present at 2019 BIO International Convention
5/29/2019
Squarex announced that it will present at the 2019 BIO International Convention, which will be held at the Pennsylvania Convention Center.
-
Squarex Announces Publication of Clinical Results for SQX770 for the Prevention of Herpes Outbreaks in Immunity, Inflammation and Disease
2/14/2019
Squarex, a clinical-stage pharmaceutical company developing a topical immunomodulator for the long-term prevention of recurrent cold sores, today announced the publication of clinical data from a clinical trial of SQX770 in patients with frequent, infrequent, or zero herpes labialis (cold sore) outbreaks per year.
-
Cold Sore Treatment Developed By Squarex Shown Effective By Immunotherapy Study
5/24/2017